ClinVar Miner

Submissions for variant NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg)

gnomAD frequency: 0.00660  dbSNP: rs12735723
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000961007 SCV001108036 benign not provided 2024-01-25 criteria provided, single submitter clinical testing
Mendelics RCV000986448 SCV001135454 uncertain significance Variegate porphyria 2019-05-28 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000986448 SCV001255186 likely benign Variegate porphyria 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Department of Medical Genomics, Royal Prince Alfred Hospital RCV000986448 SCV002538984 benign Variegate porphyria 2022-06-30 criteria provided, single submitter curation The PPOX:c.767C>G p.(Pro256Arg) variant has a gnomAD v2.1.1 FAF of 0.9288% (European non-Finnish). In a control population, allele frequency was 5%, with ~10% in the French cohort (Whatley et al 1999, PMID 10486317). In vitro functional studies found normal PPOX activity in transfected COS cells (Kauppinen et al 2001, PMID 11286631). in silico modelling predicts non-deleterious effect (REVEL score 0.495). Fulfils ACMG/AMP criteria BA1, BS3_supporting, BP4 and so is classified as Benign.
Genetics and Molecular Pathology, SA Pathology RCV000986448 SCV002556729 benign Variegate porphyria 2021-05-11 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000961007 SCV004009898 benign not provided 2023-11-01 criteria provided, single submitter clinical testing PPOX: BP4, BS1, BS2
OMIM RCV003324496 SCV000029459 pathogenic Variegate porphyria, childhood-onset 2001-04-01 no assertion criteria provided literature only
Reproductive Health Research and Development, BGI Genomics RCV000986448 SCV001142311 benign Variegate porphyria 2020-01-06 no assertion criteria provided curation NM_000309.3:c.767C>G in the PPOX gene has an allele frequency of 0.012 in European (Finnish) subpopulation in the gnomAD database, including eight homozygous occurrences. Functional studies indicated that this variant resulted in less than half of the normal PPOX activity in the prokaryotic expression system but the activity was almost normal in eukaryotic expression (PMID: 11286631). In addition, Whatley et al. reported this variant as a polymorphism (PMID: 10486317). Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1; BS2; BS3.
Clinical Genetics, Academic Medical Center RCV000961007 SCV001924864 likely benign not provided no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000961007 SCV001963218 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.